http://www.practicaldiabetes.com Practical Diabetes International EarlyView RSS Feed http://www.practicaldiabetes.com/details/journalArticle/1473825/Driving_and_hypoglycaemia_questions_and_answers.html 2012-02-06T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1473827/Management_of_hyperglycaemia_in_people_with_acute_coronary_syndromes_NICE_Clinic.html 2012-02-06T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1473829/Use_of_haemoglobin_A1c_HbA1c_in_the_diagnosis_of_diabetes_mellitus__The_implemen.html 2012-02-06T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1473831/Limitations_of_glycosylated_haemoglobin_HbA_1c__in_diabetes_screening.html Abstract Recently, glycosylated haemoglobin (HbA1c) has been recommended by the American Diabetes Association (ADA), the World Health Organisation and subsequently by many other professional bodies as a diagnostic tool for diabetes mellitus. However, the cut‐off values suggested vary between these groups and uncertainties remain regarding the limitations of this test and its effectiveness as a diagnostic tool. We wished to assess... 2012-02-06T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1473833/Diabetes_specialist_nurse_telemedicine_admissions_avoidance_costs_and_casemix.html Abstract This study aimed to describe a diabetes specialist nurse (DSN) telemedicine advice service in a university hospital diabetes service in terms of the payment by results (PbR) tariff costs, potential admissions avoidance and casemix. The source, purpose, duration, outcome and patient age were recorded prospectively over 12 months for every patient‐initiated, diabetes‐related telephone consultation. ... 2012-02-06T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1473835/Technosphere_insulin_a_new_inhaled_insulin.html 2012-02-06T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1473837/Plantar_fibromatosis_in_diabetes.html 2012-02-06T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1473839/Take_someone_under_your_wing_and_inspire_the_next_generation.html 2012-02-06T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1473841/Diazoxide.html 2012-02-06T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1473843/Erectile_dysfunction_a_weighty_issue.html Abstract Erectile dysfunction (ED) is expected to affect 322 million men by 2025. A number of lifestyle factors such as smoking, obesity, alcohol consumption and lack of physical activity are linked with erectile dysfunction. We reviewed the evidence in recent studies examining the impact of weight loss upon erectile function in obese men with and without diabetes. Esposito et al. showed that weight loss through... 2012-02-06T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1409665/Driving_and_diabetes_new_licensing_standards_by_European_Union_directive.html 2011-11-29T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1409667/Reversing_type_2_diabetes.html 2011-11-29T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1409669/Houssay_phenomenon_a_rare_case_of_diabetes_remission.html 2011-11-29T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1409671/Cost_and_effectiveness_of_exenatide_combined_with_insulin_compared_to_exenatide_.html Abstract There have been few studies investigating the use of GLP‐1 agonists in patients with insulin‐treated type 2 diabetes and none looking at the costing. We compared the efficacy and relative cost of adding exenatide treatment to patients with type 2 diabetes receiving either oral hypoglycaemic agents (OHAs) or insulin. Patients were recruited from West Suffolk Hospital Diabetes Centre. Data were acquired... 2011-11-29T00:00:00Z http://www.practicaldiabetes.com/details/journalArticle/1409673/Differences_in_metabolic_effects_of_twice_daily_versus_multiple_daily_insulin_in.html Abstract We aimed to compare children started on twice daily injections (BD) versus multiple daily injections (MDI) from diagnosis, using HbA1c and weight gain as outcome measures. In our unit, newly diagnosed children were started on BD insulin until 2005 when we changed to MDI. Those on BD were offered a change‐over to MDI. We collected data on HbA1c and body mass index standard deviation score (BMI SDS)... 2011-11-29T00:00:00Z